Table 3 Treatment duplication, the occurrence of diarrhea, drug interactions distributed across appropriate or inappropriate indication
Characteristic | Overall, N = 991 | Appropriate indication N = 571 | Inappropriate indication, N = 421 | p-value2 |
|---|---|---|---|---|
Treatment duplication | 0.024 | |||
Meropenem | 17 (61%) | 5 (45%) | 12 (71%) | |
Vancomycin | 5 (18%) | 4 (36%) | 1 (5.9%) | |
Piperacillin /Tazobactam | 4 (14%) | 0 (0%) | 4 (24%) | |
Imipenem/Cilastatin | 1 (3.6%) | 1 (9.1%) | 0 (0%) | |
Teicoplanin | 1 (3.6%) | 1 (9.1%) | 0 (0%) | |
Occurrence of diarrhea | 4 (4.0%) | 1 (1.8%) | 3 (7.1%) | 0.3 |
Drug interaction | 0(0%) | 0 (0%) | 0(0%) | 1 |